Fox Run Management, L.L.C. Akero Therapeutics, Inc. Put Options Transaction History
Fox Run Management, L.L.C.
- $526 Million
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AKRO
# of Institutions
209Shares Held
66.9MCall Options Held
321KPut Options Held
558K-
Rtw Investments, LP New York, NY6.86MShares$293 Million3.11% of portfolio
-
Janus Henderson Group PLC London, X06.03MShares$258 Million0.09% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$239 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$224 Million5.21% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.32MShares$185 Million0.01% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $1.98B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...